NALPROPION
Dead / Cancelled — Cancelled — Section 8 (as of 07 Nov 2025)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88002407
- Registration number
- 5735425
- Mark type
- Stylized text
- Filed
- 15 Jun 2018
- Published for opposition
- 20 Nov 2018
- Registered
- 23 Apr 2019
- Attorney of record
- Andrew N. Spivak
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in the treatment of obesity and inducing weight loss
Owner
- NALPROPION PHARMACEUTICALS LLC, Brentwood, TN, US
- Nalpropion Pharmaceuticals, Inc., Morristown, NJ, US
- Nalpropion Pharmaceuticals, Inc., Morristown, NJ, US
- Nalpropion Pharmaceuticals, Inc., Morristown, NJ, US
Prosecution history
- 07 Nov 2025 — CANCELLED SEC. 8 (6-YR)
- 23 Apr 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 27 Jul 2021 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 27 Jul 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 27 Jul 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 27 Jul 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 27 Jul 2021 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 23 Oct 2019 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 23 Apr 2019 — REGISTERED-PRINCIPAL REGISTER
- 16 Mar 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 15 Mar 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 12 Feb 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 22 Jan 2019 — USE AMENDMENT FILED
- 12 Feb 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 22 Jan 2019 — TEAS STATEMENT OF USE RECEIVED